Skip to main content

Table 2 Demographics and frequencies of ocular and systemic comorbidities. Data presented in Median (IQR) unless specified otherwise

From: Cataract risk stratification and prioritisation protocol in the COVID-19 era

Demographics Results
Sex (% Females) 393 (55.4)
Ethnicity (% Whites) 628 (98.4)
Age 76 (69 to 82)
Waiting List Duration in weeks 6.8 (3.9 to 9.6)
Ocular Comorbidities n (%)
 Moderate to severe AMD 31 (4.7)
 Amblyopia 11 (1.7)
 Cornea opacification 6 (0.9)
 Retinal artery/vein occlusion 6 (0.9)
 Chronic retinal degeneration 4 (0.6)
 Central visual impairment 4 (0.6)
 Optic neuropathy 2 (0.3)
 Active uveitis 1 (0.2)
 Other maculopathy (excluding AMD) 10 (1.5)
Systemic Comorbidities
 Chronic heart disease 194 (28.9)
 Diabetes 148 (22.1)
 Chronic kidney disease 139 (20.7)
 Chronic respiratory disease 66 (9.9)
 Malignancy 39 (5.8)
 Others 458 (68.3)